Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soarNovo Nordisk remains confident in its business despite potential US tariff threats, reporting strong revenue growth fueled by its weight-loss drugs.
F.D.A. Approves Weight-Loss Drug to Treat Sleep ApneaZepbound is the first ever FDA-approved medication for treating obstructive sleep apnea, particularly aimed at those with obesity.
Here's how Eli Lilly is fixing its Zepbound supply shortageEli Lilly has begun selling starter doses of Zepbound in vials online to boost supply and accessibility.
Weight-Loss Drugs Help Sleep Apnea SymptomsZepbound, Eli Lilly's weight-loss drug, showed promising results in reducing breathing problems in patients with obstructive sleep apnea, potentially increasing insurance coverage.
Eli Lilly raises price of Zepbound while trumpeting discount on starter vialsEli Lilly's Zepbound pricing strategy has both improved access with lower starter dosages while raising concerns over transparency with existing drug prices.
Zepbound shortage update: FDA issues 'limited availability' warning. When might it end?Zepbound, a weight loss drug by Eli Lilly, facing shortage in certain doses in the U.S. due to increased demand.
F.D.A. Approves Weight-Loss Drug to Treat Sleep ApneaZepbound is the first ever FDA-approved medication for treating obstructive sleep apnea, particularly aimed at those with obesity.
Here's how Eli Lilly is fixing its Zepbound supply shortageEli Lilly has begun selling starter doses of Zepbound in vials online to boost supply and accessibility.
Weight-Loss Drugs Help Sleep Apnea SymptomsZepbound, Eli Lilly's weight-loss drug, showed promising results in reducing breathing problems in patients with obstructive sleep apnea, potentially increasing insurance coverage.
Eli Lilly raises price of Zepbound while trumpeting discount on starter vialsEli Lilly's Zepbound pricing strategy has both improved access with lower starter dosages while raising concerns over transparency with existing drug prices.
Zepbound shortage update: FDA issues 'limited availability' warning. When might it end?Zepbound, a weight loss drug by Eli Lilly, facing shortage in certain doses in the U.S. due to increased demand.
Nurse's death linked to approved weight-loss drugThe death of nurse Susan McGowan has raised concerns over the safety of the weight-loss drug Mounjaro, linked to her unexpected health decline.
BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the NasdaqBioAge Labs is entering the public market with its obesity drug Azelaprag in clinical trials, aiming for significant growth and competition in the weight loss sector.